前收市價 | 11.70 |
開市 | 12.19 |
買盤 | 0.00 x 0 |
賣出價 | 0.00 x 0 |
今日波幅 | 11.65 - 12.19 |
52 週波幅 | 3.42 - 14.50 |
成交量 | |
平均成交量 | 542,380 |
市值 | 2.316B |
Beta 值 (5 年,每月) | 1.46 |
市盈率 (最近 12 個月) | 無 |
每股盈利 (最近 12 個月) | -2.26 |
業績公佈日 | 2024年8月07日 - 2024年8月12日 |
遠期股息及收益率 | 無 (無) |
除息日 | 無 |
1 年預測目標價 | 17.70 |
A change in classification is moving closer to reality. Multistate weed sellers would be the immediate beneficiaries.
Many investors and analysts have been bullish on the prospects of the U.S. cannabis industry since its legalization in several states. However, despite being legal in 40 out of 50 U.S. states for medical use and 24 out of 50 for recreational, the drug is still not federally legal. Many people have gotten excited about federal legalization prospects, as news of a potential rescheduling has broken out. More specifically, the Department of Justice has recommended that cannabis be rescheduled as a S
Curaleaf CEO Matt Darin said it was "a historic moment" for the cannabis industry following reports that the DEA is seeking to reschedule marijuana. Here are some of the implications for the weed industry.